Vaccine Therapy in Treating Patients With Metastatic Melanoma

NCT00002817 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: sargramostim
BIOLOGICAL: vaccinia-GM-CSF vaccine

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]